Capital Rx Secures $50M in Series B Financing

Capital Rx

Capital Rx, a NYC-based pharmacy benefit manager, raised $50m in Series B financing.

The round was led by Transformational Capital, with participation from Edison Partners.

The company intends to use the funds to expand the platform’s capabilities, including leveraging AI to improve clinical care.

Led by AJ Loiacono, CEO, Capital Rx is a health technology company which provides an enterprise pharmacy platform digitally linking providers, patients, pharmacies.  Since its inception, the company has grown to service hundreds of thousands of members and process millions of prescriptions annually.